FINLIUS

Serial Number 98277784
730

Registration Progress

Application Filed
Nov 20, 2023
Under Examination
Sep 24, 2024
Approved for Publication
Jul 30, 2024
Published for Opposition
Jul 30, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Sep 24, 2025 70 days

Trademark Image

FINLIUS

Basic Information

Serial Number
98277784
Filing Date
November 20, 2023
Published for Opposition
July 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Dec 12, 2024
Application
Pending
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
70 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 24, 2025
Extension Available
Until September 24, 2025

Application History

12 events
Date Code Type Description Documents
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 12, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 12, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 24, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 2, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 23, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of autoimmune diseases and disorders

Classification

International Classes
005